Document is current
Any future updates will be listed below
-
Authors
Zimbalist, Alexa S.
Caan, Bette J.
Chen, Wendy Y.
Mittendorf, Elizabeth A.
Dillon, Deborah A. R.
Quesenberry, Charles
Cespedes Feliciano, Elizabeth M.
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (R01CA251589, R01CA251589, R01CA251589, R01CA251589, R01CA251589, R01CA251589, R01CA251589)
American Institute for Cancer Research (632996, 632996)
- License Information
-
More Information
Article History
Received: 1 September 2022
Accepted: 9 December 2022
First Online: 29 December 2022
Declarations
:
: The study was approved by the Kaiser Permanente Northern California Institutional Review Board. The need for written informed consent to participate in the study was waived by the Kaiser Permanente Northern California Institutional Review Board.
: Not applicable.
: Dr. Elizabeth Mittendorf discloses consulting fees, advisory board membership and/or sponsored research agreements from Exact Sciences, Merck, and Roche/Genentech. These were unrelated to this work. Dr. Deborah Dillon discloses contracted research from Canon, Inc and advisory board membership with Oncology Analytics, Inc. These were unrelated to this work. Ms. Zimbalist and Drs. Caan, Chen, Quesenberry, and Cespedes Feliciano have no competing interests to disclose.
